skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.2.2

Opposition

Number:91181009Filing Date:11/30/2007
Status:TerminatedStatus Date:07/30/2009
General Contact Number:571-272-8500
Interlocutory Attorney:GEORGE POLOGEORGIS
Paralegal Name:ELLEN YOWELL
Defendant
Name:NBTY Acquisition LLC
Correspondence:Michael A. Painter
Isaacman, Kaufman & Painter
8484 Wilshire Blvd., Suite 850
Beverly Hills, CA 90211-3235
UNITED STATES

Phone: 323-782-7700
 
Serial #:76675003Application FileAssignment
Application Status: Abandoned - After Inter-Partes Decision
Mark: AIRSAFE
Plaintiff
Name:Arisaph Pharmaceuticals, Inc.
Correspondence:Joshua S. Jarvis, Esq.
Foley Hoag LLP
155 Seaport Boulevard
Boston, MA 02210-2600
UNITED STATES
ustrademark@foleyhoag.com
Phone: 617-832-3018
 
Serial #:77096989Application FileAssignmentRegistration #:3521328
Application Status: Cancelled - Section 8
Mark: A ARISAPH CREATING SMART MEDICINES
 
Serial #:77097806Application FileAssignment
Application Status: Abandoned - No Statement Of Use Filed
Mark: A ARISAPH CREATING SMART MEDICINES
 
Serial #:78752478Application FileAssignmentRegistration #:3235287
Application Status: Cancelled - Section 8
Mark: ARISAPH CREATING SMART MEDICINES
 
Serial #:78691203Application FileAssignmentRegistration #:3166776
Application Status: REGISTERED AND RENEWED
Mark: ARISAPH
Granted To Date:12/19/2007
Prosecution History
#DateHistory TextDue Date
1107/30/2009TERMINATED
1007/30/2009BD'S DECISION: DISMISSED W/O PREJUDICE
907/29/2009WITHDRAWAL OF APPLICATION
807/13/2009TRIAL DATES RESET
705/25/2009RESPONSE DUE 30 DAYS (DUE DATE)06/24/2009
605/10/2008SUSPENDED
504/14/2008DF'S MOTION TO SUSPEND
401/04/2008ANSWER
312/02/2007PENDING, INSTITUTED
212/02/2007NOTICE AND TRIAL DATES SENT; ANSWER DUE:01/11/2008
111/30/2007FILED AND FEE
Results as of 12/05/2022 03:37 AM
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY